• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宾夕法尼亚大学阿尔茨海默病研究中心远程统一数据集神经心理成套测验的可行性、有效性和常模数据。

Feasibility, validity, and normative data for the remote Uniform Data Set neuropsychological battery at the University of Pennsylvania Alzheimer's Disease Research Center.

作者信息

Hackett Katherine, Shi Yidan, Schankel Laura, Oliveira Nicole, Kelley Melissa, McCoubrey Hannah, Peskin Sara Manning, O'Brien Kyra, Xie Sharon X, Wolk David, Mechanic-Hamilton Dawn

机构信息

Department of Psychology and Neuroscience Temple University Philadelphia Pennsylvania USA.

Present address: Division of General Internal Medicine Icahn School of Medicine at Mount Sinai New York NY 10029 USA.

出版信息

Alzheimers Dement (Amst). 2024 Dec 26;16(4):e70043. doi: 10.1002/dad2.70043. eCollection 2024 Oct-Dec.

DOI:10.1002/dad2.70043
PMID:39726731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670303/
Abstract

INTRODUCTION

We investigated the feasibility and validity of the remotely-administered neuropsychological battery from the National Alzheimer's Coordinating Center Uniform Data Set (UDS T-Cog).

METHODS

Two hundred twenty Penn Alzheimer's Disease Research Center participants with unimpaired cognition, mild cognitive impairment, and dementia completed the T-Cog during their annual UDS evaluation. We assessed administration feasibility and diagnostic group differences cross-sectionally across telephone versus videoconference modalities, and compared T-Cog to prior in-person UDS scores longitudinally.

RESULTS

Administration time averaged 54 min and 79% of participants who initiated a T-Cog completed all 12 subtests; completion time and rates differed by diagnostic group but not by modality. Performance varied expectedly across groups with moderate to strong associations between most T-Cog measures and in-person correlates, although select subtests demonstrated lower comparability.

DISCUSSION

The T-Cog is feasibly administered and shows preliminary validity in a cognitively heterogeneous cohort. Normative data from this cohort should be expanded to more diverse populations to enhance utility and generalizability.

HIGHLIGHTS

This study examined the feasibility and validity of the remote Uniform Data Set (also known as the T-Cog) and contributes key normative data for widespread use.A remote neuropsychological battery was feasibly administered with high overall engagement and completion rates, adequate reliability compared to in-person testing, and evidence of validity across diagnostic groups.Typical barriers to administration included hearing impairment, technology issues, and distractions; hearing difficulties were particularly common among cognitively impaired groups.Certain tests were less closely related to their in-person correlates and should be used with caution.

摘要

引言

我们研究了来自国家阿尔茨海默病协调中心统一数据集(UDS T-Cog)的远程管理神经心理测试组合的可行性和有效性。

方法

220名宾夕法尼亚阿尔茨海默病研究中心的参与者,他们认知功能未受损、有轻度认知障碍和痴呆,在年度UDS评估期间完成了T-Cog测试。我们横断面评估了通过电话与视频会议方式进行测试的管理可行性以及诊断组差异,并纵向比较了T-Cog与之前现场UDS评分。

结果

测试管理平均用时54分钟,启动T-Cog测试的参与者中有79%完成了所有12个分测试;完成时间和完成率因诊断组而异,但不因测试方式而异。各诊断组的表现符合预期,大多数T-Cog测试指标与现场测试指标之间存在中度到强的相关性,不过部分分测试的可比性较低。

讨论

T-Cog测试管理可行,且在认知功能异质性队列中显示出初步有效性。该队列的常模数据应扩展到更多样化的人群,以提高实用性和普遍性。

要点

本研究检验了远程统一数据集(也称为T-Cog)的可行性和有效性,并为广泛应用贡献了关键的常模数据。远程神经心理测试组合管理可行,总体参与度和完成率高,与现场测试相比具有足够的可靠性,且在各诊断组中均有有效性证据。测试管理的典型障碍包括听力障碍、技术问题和干扰因素;听力困难在认知受损组中尤为常见。某些测试与现场测试指标的相关性较低,应谨慎使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/a0fa8cc27277/DAD2-16-e70043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/33ec74fc0ac9/DAD2-16-e70043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/b49f1f659ab1/DAD2-16-e70043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/837f324dba30/DAD2-16-e70043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/bdd936d1b6e3/DAD2-16-e70043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/a0fa8cc27277/DAD2-16-e70043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/33ec74fc0ac9/DAD2-16-e70043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/b49f1f659ab1/DAD2-16-e70043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/837f324dba30/DAD2-16-e70043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/bdd936d1b6e3/DAD2-16-e70043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4600/11670303/a0fa8cc27277/DAD2-16-e70043-g003.jpg

相似文献

1
Feasibility, validity, and normative data for the remote Uniform Data Set neuropsychological battery at the University of Pennsylvania Alzheimer's Disease Research Center.宾夕法尼亚大学阿尔茨海默病研究中心远程统一数据集神经心理成套测验的可行性、有效性和常模数据。
Alzheimers Dement (Amst). 2024 Dec 26;16(4):e70043. doi: 10.1002/dad2.70043. eCollection 2024 Oct-Dec.
2
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
3
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
6
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
7
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
8
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
9
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting.用于在社区环境中诊断阿尔茨海默病性痴呆及其他痴呆症的简易认知功能测试。
Cochrane Database Syst Rev. 2015 Feb 3(2):CD010860. doi: 10.1002/14651858.CD010860.pub2.
10
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.

本文引用的文献

1
Lessons From the Coronavirus Disease Experience: Research Participant and Staff Satisfaction With Remote Cognitive Evaluations.从冠状病毒病经验中吸取的教训:研究参与者和工作人员对远程认知评估的满意度。
Alzheimer Dis Assoc Disord. 2024;38(1):65-69. doi: 10.1097/WAD.0000000000000605. Epub 2024 Feb 12.
2
Feasibility of Remote Administration of the Uniform Data Set-Version 3 for Assessment of Older Adults With Mild Cognitive Impairment and Alzheimer's Disease.远程管理统一数据组第 3 版评估轻度认知障碍和阿尔茨海默病老年人的可行性。
Arch Clin Neuropsychol. 2024 Jul 24;39(5):635-643. doi: 10.1093/arclin/acae001.
3
Comparison of performance on the oral versus written trail making test in patients with movement disorders.
运动障碍患者在口头与书面连线测验中的表现比较。
Appl Neuropsychol Adult. 2023 Dec 8:1-7. doi: 10.1080/23279095.2023.2288230.
4
Tele-Neuropsychology: From Science to Policy to Practice.远程神经心理学:从科学到政策再到实践。
Arch Clin Neuropsychol. 2024 Feb 19;39(2):227-248. doi: 10.1093/arclin/acad066.
5
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis.美国医疗保险人群中轻度认知障碍和痴呆的预期和诊断率:观察性分析。
Alzheimers Res Ther. 2023 Jul 22;15(1):128. doi: 10.1186/s13195-023-01272-z.
6
If You Give Them Away, It Still May Not Work: Challenges to Video Telehealth Device Use Among the Urban Homebound.即使免费赠送,视频远程医疗设备的使用仍然可能面临挑战:城市居家患者面临的难题。
J Appl Gerontol. 2023 Sep;42(9):1896-1902. doi: 10.1177/07334648231170144. Epub 2023 Apr 18.
7
Reliability of the NACC Telephone-administered Neuropsychological Battery (T-cog) and Montreal Cognitive Assessment for participants in the USC ADRC.南加州大学阿尔茨海默病研究中心(USC ADRC)参与者的NACC电话神经心理测验组合(T-cog)和蒙特利尔认知评估的可靠性。
Alzheimers Dement (Amst). 2023 Mar 8;15(1):e12406. doi: 10.1002/dad2.12406. eCollection 2023 Jan-Mar.
8
Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report.解决阿尔茨海默病治疗试验中多样性的重大缺陷:一项 CTAD 工作组报告。
J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50.
9
Neuropsychology's race problem does not begin or end with demographically adjusted norms.神经心理学的种族问题并非始于或止于经人口统计学调整的常模。
Nat Rev Neurol. 2022 Mar;18(3):125-126. doi: 10.1038/s41582-021-00607-4.
10
What the Aducanumab Approval Reveals About Alzheimer Disease Research.阿杜卡努单抗获批对阿尔茨海默病研究的启示
JAMA Neurol. 2021 Nov 1;78(11):1305-1306. doi: 10.1001/jamaneurol.2021.3404.